Front-Line Management of Mantle Cell Lymphoma in Canada: A Practical, Risk-Adapted Approach
Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma (NHL) that accounts for approximately 5–7% of all lymphomas.1 Its clinical presentation is heterogeneous, ranging from an indolent leukemic non-nodal subtype that may be managed with observation to highly aggressive disease characterized by TP53 alterat...